We are monitoring the impact of COVID-19 on Latin America HPAPI Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2907
Share on
Share on

Latin America High Potency API Market Research Report – Segmented By Type, Synthesis, Therapeutic Application & Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2907
Pages: 145

Latin America HPAPI Market Size (2021 to 2026)

The size of the Latin America High Potency APIs market was valued at USD 2.56 billion in 2021. It is further estimated to be growing at a CAGR of 8.3% and value USD 3.81 billion by 2026.

High Potency Active Pharmaceutical Ingredients (HPAPI) are pharmacologically active substances and intermediates at concentrations below 150 micrograms per kilogram of body weight. They are highly selective; hence they can bind to specific receptors or enzymes, which can cause cancer, reproductive problems, and developmental disorders at low doses. Many new pharmaceutical drugs have these drugs, leading to the high growth of this market.

High Potency Active Pharmaceutical Ingredients gave rise to a new set of medicines to treat medical ailments, especially cancer. The mapping of the human genome gave the possibility of producing new cancer-treating drugs for different cancers and different patients. Since they are active even at low concentrations, they have to be prepared with great care. They can cause serious health issues to workers if proper care is not taken. Safety steps are to be taken to prevent the contamination of drugs with contaminants. So, it requires specialized equipment for handling HPAPI’s and managing air quality.

Some of the driving factors of Latin America High Potency Active Pharmaceutical Ingredients market are low prices, growing healthcare prices, rising government initiatives to increase the usage of generic medicines so that healthcare costs can be cut down, rising number of pharmaceutical manufacturers and patients.

This market's restraining agents are lack of skilled workers, stringent regulatory requirements, and the high price of equipment.

This research report on the Latin America HPAPI Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Innovative HPAPI's
  • Generic HPAPI's

By Synthesis: 

  • Biotech HPAPI's
  • Synthetic HPAPI's

By Therapeutic Application: 

  • Oncology
  • Glaucoma
  • Hormonal Balance

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, this market is still in its initial stages in this region. Factors such as the growing incidence of cancer, increased funding into cancer research, and approval for new drugs' production are expected to amplify this market's growth in the region.

Noteworthy Companies dominating the Latin America High Potency Active Pharmaceutical Ingredients Market profiled in the report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

1.Introduction                                                               

               1.1 Market Definition                                                  

               1.2 Study Deliverables                                                 

               1.3 Base Currency, Base Year and Forecast Periods                                                         

               1.4 General Study Assumptions                                                

2. Research Methodology                                                                        

               2.1 Introduction                                             

               2.2 Research Phases                                                    

                              2.2.1 Secondary Research                                          

                              2.2.2 Primary Research                                

                              2.2.3 Econometric Modelling                                    

                              2.2.4 Expert Validation                                 

               2.3 Analysis Design                                                       

               2.4 Study Timeline                                                        

3. Overview                                                                   

               3.1 Executive Summary                                               

               3.2 Key Inferences                                                        

               3.3 Epidemology                                                           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                      

               4.1 Market Drivers                                                       

               4.2 Market Restraints                                                  

               4.3 Key Challenges                                                       

               4.4 Current Opportunities in the Market                                               

5. Market Segmentation                                                            

               5.1 Type                                                           

                              5.1.1 Innovative HPAPI's                              

                              5.1.2 Generic HPAPI's                                   

                              5.1.3  Y-o-Y Growth Analysis, By Type                                    

                              5.1.4  Market Attractiveness Analysis, By Type                                    

                              5.1.5  Market Share Analysis, By Type                                    

               5.2 Synthesis                                                   

                              5.2.1 Biotech HPAPI's                                   

                                             5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type               

                                                            5.2.1.1.1 Innovative Biotech HPAPIs         

                                                            5.2.1.1.2 Biosimilars       

                              5.2.2 Synthetic HPAPI's                                

                                             5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type              

                                                            5.2.2.1.1 Innovative Synthetic HPAPIs      

                                                            5.2.2.1.2 Generic Synthetic HPAPIs           

                              5.2.3 Y-o-Y Growth Analysis, By Synthesis                                            

                              5.2.4 Market Attractiveness Analysis, By Synthesis                                            

                              5.2.5 Market Share Analysis, By Synthesis                                            

               5.3 Therapeutic Application                                                      

                              5.3.1 Oncology                               

                              5.3.2 Glaucoma                              

                              5.3.3 Hormonal Balance                              

                              5.3.4 Other therapeutic applications                                      

                              5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application                                 

                              5.3.6  Market Attractiveness Analysis, By Therapeutic Application                               

                              5.3.7  Market Share Analysis, By Therapeutic Application                                

               5.4 Manufacturer                                                         

                              5.4.1 Captive Manufacturers                                     

                              5.4.2 Merchant Manufacturers                                 

                                             5.4.2.1 Merchant HPAPI Manufacturers Market, By Type                 

                                                            5.4.2.1.1 Innovative Merchant HPAPI Manufacturers         

                                                            5.4.2.1.2 Generic Merchant HPAPI Manufacturers              

                                             5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis                             

                                                            5.4.2.2.1 Synthetic HPAPIs           

                                                            5.4.2.2.2 Biotech HPAPIs              

                              5.4.3 Y-o-Y Growth Analysis, By Manufacturer                                    

                              5.4.4  Market Attractiveness Analysis, By Manufacturer                                  

                              5.4.5  Market Share Analysis, By Manufacturer                                   

6. Geographical Analysis                                                            

               6.1 Introduction                                             

                              6.1.1 Regional Trends                                   

                              6.1.2 Impact Analysis                                    

                              6.1.3 Y-o-Y Growth Analysis                                       

                                             6.1.3.1 By Type                

                                             6.1.3.2 By Synthesis                       

                                             6.1.3.3 By Therapeutic Application                           

                                             6.1.3.4 By Manufacturer               

                              6.1.4  Market Attractiveness Analysis                                     

                                             6.1.4.1 By Type                

                                             6.1.4.2 By Synthesis                       

                                             6.1.4.3 By Therapeutic Application                           

                                             6.1.4.4  By Manufacturer                             

                              6.1.5  Market Share Analysis                                      

                                             6.1.5.1 By Type                

                                             6.1.5.2 By Synthesis                       

                                             6.1.5.3 By Therapeutic Application                           

                                             6.1.5.4 By Manufacturer               

               6.2 Brazil                                                         

               6.3 Mexico                                                      

               6.4 Rest of Latin America                                                          

7.Strategic Analysis                                                                     

               7.1 PESTLE analysis                                                      

                              7.1.1 Political                                  

                              7.1.2 Economic                               

                              7.1.3 Social                                      

                              7.1.4 Technological                                      

                              7.1.5 Legal                                       

                              7.1.6 Environmental                                     

               7.2 Porter’s Five analysis                                            

                              7.2.1 Bargaining Power of Suppliers                                       

                              7.2.2 Bargaining Power of Consumers                                   

                              7.2.3 Threat of New Entrants                                    

                              7.2.4 Threat of Substitute Products and Services                                

                              7.2.5 Competitive Rivalry within the Industry                                      

8.Market Leaders' Analysis                                                                       

               8.1 Pfizer Inc.                                                 

                              8.1.1 Overview                                

                              8.1.2 Product Analysis                                  

                              8.1.3 Financial analysis                                 

                              8.1.4 Recent Developments                                       

                              8.1.5 SWOT analysis                                     

                              8.1.6 Analyst View                                         

               8.2 Novartis International AG                                                   

               8.3 Sanofi                                                        

               8.4 F. Hoffmann-La Roche Ltd.                                                

               8.5 Eli Lilly and Company                                                           

               8.6 Bristol-Myers Squibb                                                            

               8.7 Boehringer Ingelheim                                                          

               8.8 Teva Pharmaceutical Industries Ltd.                                                

               8.9 Merck & Co., Inc.                                                   

               8.10 AbbVie Inc.                                                            

               8.11 Mylan Inc.                                              

9.Competitive Landscape                                                                         

               9.1 Market share analysis                                                          

               9.2 Merger and Acquisition Analysis                                                       

               9.3 Agreements, collaborations and Joint Ventures                                                         

               9.4 New Product Launches                                                        

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                        

               a) List of Tables                                              

               b) List of Figures                                            

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Billion)
  2. Latin America Innovative HPAPI's  Market, By Region, From 2021 to 2026 (USD Billion)
  3. Latin America Generic HPAPI's Market, By Region, From 2021 to 2026 (USD Billion)
  4. Latin America High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Billion)
  5. Latin America Biotech HPAPI's Market, By Region, From 2021 to 2026 (USD Billion)
  6. Latin America Synthetic HPAPI's Market, By Region, From 2021 to 2026 (USD Billion)
  7. Latin America High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Billion)
  8. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  9. Latin America Glaucoma Market, By Region, From 2021 to 2026 (USD Billion)
  10. Latin America Hormonal Balance Market, By Region, From 2021 to 2026 (USD Billion)
  11. Latin America other therapeutic applications Market, By Region, From 2021 to 2026 (USD Billion)
  12. Brazil High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Billion)
  13. Brazil High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Billion)
  14. Brazil High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Billion)
  15. Argentina High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Billion)
  16. Argentina High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Billion)
  17. Argentina High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Billion)
  18. Mexico High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Billion)
  19. Mexico High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Billion)
  20. Mexico High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Billion)
  21. Rest of Latin America High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Billion)
  22. Rest of Latin America High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Billion)
  23. Rest of Latin America High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample